大量淋巴血管间隙浸润对淋巴结阴性FIGO I期子宫癌患者的预后影响
本研究回顾了1052例2009-FIGO I期子宫内膜样腺癌且病理淋巴结阴性患者的病理标本,量化淋巴血管间隙浸润(LVSI)为局灶或大量。中位随访9.7年,大量LVSI与局灶LVSI在5年无复发生存、疾病特异性生存、总生存及初始复发模式上均无统计学显著差异。
要点
- 在淋巴结阴性I期子宫内膜样腺癌中,大量LVSI与局灶LVSI的5年无复发生存无统计学显著差异。
- 大量LVSI与局灶LVSI相比,疾病特异性生存、总生存及初始复发模式均无统计学显著差异。
- 年龄≥60岁和更高级别是更差无复发生存、疾病特异性生存和总生存的预测因素。
核心结论
- 在病理淋巴结阴性的I期子宫内膜样腺癌患者中,与局灶LVSI相比,大量LVSI并不预示更差的生存终点或不同的复发模式。
研究设计与样本
- 回顾性研究,纳入1052例2009-FIGO I期子宫内膜样腺癌且接受子宫切除术及病理淋巴结阴性评估的患者,中位随访9.7年。
主要发现
- 907例(86.2%)无LVSI,87例(8.3%)为局灶LVSI,58例(5.5%)为大量LVSI。
- 5年无复发生存率:无LVSI为93.3%(95%CI 91.5-95.1),局灶LVSI为76.8%(95%CI 67.2-87.7),大量LVSI为79.1%(95%CI 67.6-95.3),P<0.0001。
- 局灶LVSI与大量LVSI两组在5年无复发生存、疾病特异性生存、总生存及初始复发模式上均无统计学显著差异。
- 倾向性评分匹配的多因素分析中,与局灶LVSI相比,大量LVSI与任何生存终点均无独立关联,但两者与无LVSI相比均不利。
- 年龄≥60岁和更高级别是更差无复发生存、疾病特异性生存和总生存的预测因素;合并症负担是总生存的独立预测因素。
临床怎么用
- 作者认为,对于病理淋巴结阴性的I期子宫内膜样腺癌患者,大量LVSI与局灶LVSI相比并不预示更差的生存终点或不同的复发模式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Substantial lymphovascular space invasion (LVSI) is an important predictor of lymph node (LN) involvement in women with endometrial carcinoma. We studied the prognostic significance of substantial LVSI in patients with 2009-FIGO stage-I uterine endometrioid adenocarcinoma (EC) who all had pathologic negative nodal evaluation (PNNE). METHODS: Pathologic specimens were retrieved and LVSI was quantified (focal or substantial) in women with stage-I EC who had a hysterectomy and PNNE. In addition to multivariate analysis (MVA), recurrence-free (RFS), disease-specific (DSS), and overall (OS) survival was compared between women with focal vs. substantial LVSI. RESULTS: 1052 patients were identified with a median follow-up of 9.7 years. 358 women (34%) received adjuvant radiotherapy. 907 patients (86.2%) had no LVSI, 87 (8.3%) had focal, and 58 (5.5%) had substantial LVSI. Five-year RFS was 93.3% (95% CI: 91.5-95.1), 76.8% (95% CI: 67.2-87.7) and 79.1% (95% CI: 67.6-95.3) for no, focal, and substantial LVSI(p < 0.0001). There was no statistically significant difference in 5-year RFS, DSS, OS, and in the patterns of initial recurrence between women with focal vs substantial LVSI. On MVA with propensity score matching, substantial LVSI was not independently associated with any survival endpoint compared to focal LVSI, albeit both were detrimental when compared to no LVSI. Age ≥ 60 years and higher grade were predictors of worse RFS, DSS, and OS. Additionally, comorbidity burden was an independent predictor for OS. CONCLUSIONS: Our results suggest that substantial LVSI does not predict worse survival endpoints or different recurrence patterns in women with stage-I EC with PNNE when compared to focal LVSI.
引用
- Bhatnagar AR, Ghanem AI, Alkamachi B, et al. The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma. Gynecol Oncol. 2024. PMID: 38936280. doi:10.1016/j.ygyno.2024.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。